Onkologie. 2011:5(5):270-273

Surgery and miniinvasive treatment of colorectal carcinoma

Zdeněk Kala1, Petr Kysela1, Lenka Ostřížková2, Igor Kiss3, Vlastimil Válek4, Tomáš Andrašina4
1 Chirurgická klinika FN Brno a LF MU Brno
2 Interní hematoonkologická klinika FN Brno a LF MU Brno
3 Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno
4 Radiologická klinika FN Brno a LF MU Brno

Background: The incidence of colorectal carcinoma has been increasing. Only a multimodal treatment provides the best results. Surgical

R0 resection of all tumour sites is the goal of all treatment regimes.

Material and methods: A survey on the literature and our experiences has been conducted.

Results: Surgical treatment comprises endoscopic submucosal dissection, transanal endoscopic microsurgery, laparoscopy, open surgery

and cytoreduction surgery with the hyperthermic intraperitoneal chemotherapy. The news is the total mesocolic excision that similarly

to the total mesorectal excision provides fewer local relapses and higher long-term survival.

Conclusion: Similarly to anti-tumoral medical therapy, the surgery has been developing as well. It is necessary to enrol the patients into

suitable databases to state the proper position of all surgical methods in the multimodal treatment algorithm.

Keywords: colorectal carcinoma, treatment, miniinvasive, endoscopy, laparoscopy

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kala Z, Kysela P, Ostřížková L, Kiss I, Válek V, Andrašina T. Surgery and miniinvasive treatment of colorectal carcinoma. Onkologie. 2011;5(5):270-273.
Download citation

References

  1. Cole WH. Precautions in the spread of carcinoma of the colon and rectum. Ann Surg 1954; 40: 135-136. Go to original source... Go to PubMed...
  2. Turnbull RB, Jr, Kyle K, Watson FR, et al. Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg 1967; 166: 420-427. Go to original source... Go to PubMed...
  3. Grinnell RS. Distal intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol Obstet 1954; 99: 421-30.
  4. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for Colon and Rectal Cancer Surgery. JNCI J Natl Cancer Inst 2001; 93 (8): 583-596. doi: 10.1093/jnci/93.8.583. Go to original source... Go to PubMed...
  5. Cohen ME. Morbidity and mortality risk-calculator for colorectal surgery. European Colorectal Congress 2010, St. Gallen, Ch.
  6. Rullier E. Risk factors for anastomotic leakage after resection of rectal cancer. European Colorectal Congress 2010, St. Gallen, Ch.
  7. Jeekel J. Colon anastomosis leackage: cause and prevention. European Colorectal Congress 2010, St. Gallen, Ch.
  8. Terwisscha Van Scheltinga SE, Den Boer FC, Pijpers R, et al. Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining. Scand J Gastroenterol Suppl 2006; (243): 153-157. Go to original source... Go to PubMed...
  9. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: A population-based study. Ann Surg 2006; 244: 602-610. Go to original source... Go to PubMed...
  10. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT0089. J Clin Oncol 2003; 21: 2912-2919. Go to original source... Go to PubMed...
  11. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982; 69: 613-616. Go to original source... Go to PubMed...
  12. Gunderson LL, Sargent DJ, Tepper JB, et al. Impact of T and M stage and treatment on survival and relapse in adj. rectal cancer. J Clin Oncol. 2004; 22: 1785-96. Go to original source... Go to PubMed...
  13. Kusters M, Wallner C, Lange MM, et al. Origin of presacral local recurrence after rectal cancer treatmment. BJS 2010; 97: 1582-1587. Go to original source... Go to PubMed...
  14. Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Disease 2009; 11: 354-365. Go to original source... Go to PubMed...
  15. Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 2003; 63(14): 4253-4257.
  16. Jung H, Beck-Bornholdt H-P, Svoboda V, et al. Quantification of late complications after radiation therapy. Radiotherapy and Oncology 2001; 61(3): 233-246. Go to original source... Go to PubMed...
  17. Chamlou R, Parc Y, Simon T, et al. Long-term results of intesphincteric resection for low rectal cancer. Ann Surg. 2007; 245: 88-93. Go to original source... Go to PubMed...
  18. Hoerske C, Weber K, Goehl J, et al. Long-term outcomes and quality of life after rectal carcinoma surgery. BJS 2010; 97: 1295-1303. Go to original source... Go to PubMed...
  19. Nash GM, Weser MR, Guillem JG, et al. Long-term survival after excision of T1 rectal cancer. Dis Colon Rectum 2009; 52: 577-582. Go to original source... Go to PubMed...
  20. Rasheed S, Bowley DM, Aziz O, et al. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis 2008; 10(3): 231-238. Go to original source... Go to PubMed...
  21. Kennedy GD. Laparoscopy decreases postoperative complication rates after abdominal colectomy: results from the national surgical quality improvement program Ann Surg 2009; 249: 596-601. Go to original source... Go to PubMed...
  22. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010; 11(7): 637-45 doi: 10.1016/S1470-2045(10)70131-5. Go to original source... Go to PubMed...
  23. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-years results of the UK MEC CLASSIC trial group. J Clin Oncol 2007; 25(21): 3061-3068. Go to original source... Go to PubMed...
  24. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363. Go to original source...
  25. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221(2): 124-132. Go to original source... Go to PubMed...
  26. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28(1): 63-68. Go to original source... Go to PubMed...
  27. Shen P, Thai K, Stewart JH, et al. Peritoneal surface disease from colorectal cancer; Comparison to the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol 2008; 15: 3422-3432. Go to original source... Go to PubMed...
  28. Carmignani CP, Ortega-Perez G, Sugarbaker PH. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 2004; 30: 391-398. Go to original source... Go to PubMed...
  29. Elias D Elias D, Liberale G, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005; 12(11) 900-909. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.